Table 1.
Patients baseline characteristics (n = 40)
|
Age (in years/range) |
38-84 |
|
Sex |
|
| ♀ |
65% |
| ♂ |
35% |
|
N stage |
|
| N0 |
23% |
| N1 |
39% |
| N3 |
3% |
|
Distant metastasis |
|
| At diagnosis |
22.5% |
| In the course of treatment |
27.5% |
|
Surgery |
|
| Total thyroidectomy |
68% |
| Subtotal thyroidectomy |
12% |
|
Resection status |
|
| R0 |
10% |
| R1 |
50% |
| R2 |
7.5% |
| Rx |
32.5% |
| Removal of lymph nodes |
32.5% |
|
Chemotherapy |
15% |
|
Radiotherapy: |
97.5% |
| Opposing field technique |
49.5% |
| 3-d-conformal technique |
14% |
| Combination of both |
32.5% |
| Period between operation and radiation (in days/range) |
13 (2–399) |
| Median applied dose (Gy/range) |
50 (6–60.4) |
|
Fractionation schedules |
|
| Daily radiation |
87.5% |
| Twice daily radiation |
7.5% |
| Radiation every second day | 7.5% |